Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
Rachel Yamin, Andrew Jones, Hans-Heinrich Hoffmann, Alexandra Schäfer, Kevin S. Kao, Rebecca Francis, Timothy P. Sheahan, Ralph S. Baric, Charles M. Rice, Jeffrey V. Ravetch, Stylianos Bournazos
Topics & Concepts
Monoclonal antibodyAntibodyMedicineImmunologyCoronavirus disease 2019 (COVID-19)DiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)EffectorVirologyMonoclonalInfectious disease (medical specialty)Internal medicineSARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies ResearchCOVID-19 Clinical Research Studies